
	Recovery Period	September 30, 2026		December 31, 2025
Regulatory Assets
Property-related temporary differences (tax benefits flowed through to customers)	Indefinite	$	199,465	$	199,465
Asset retirement obligations, net	Indefinite	32,340		30,073
Other accrued benefits	Indefinite	28,406		26,263
Tank coating	Various	17,753		19,495
M-WRAM long-term regulatory asset	1 - 2 years	13,307		12,876
IRMA long-term accounts receivable	Various	11,165		22,077
Incremental Cost Balancing Accounts (ICBA)	1 year	8,507		4,722
Recoverable property losses	Various	1,609		2,051
General District Balancing Account (GDBA) long-term accounts receivable	Various	744		9,844
Customer Assistance Program and Rate Support Fund accounts receivable		—		2,651
Net WRAM and Modified Cost Balancing Account (MCBA) long-term accounts receivable		—		4,078
Other regulatory assets	Various	6,819		6,270
Total Regulatory Assets		$	320,115	$	339,865
Regulatory Liabilities
Cost of removal		$	548,503	$	523,813
Pension and retiree group health		216,972		219,133
Future tax benefits due to customers		101,930		103,662
Other components of net periodic benefit cost		30,180		24,248
Conservation Expense Balancing Account (CEBA)		5,929		5,202
Customer Assistance Program and Rate Support Fund accounts payable		4,237		—
PFAS settlement proceeds		3,397		25,193
ICBA		3,129		2,144
Health Cost Balancing Account (HCBA)		2,497		4,149
Pension Cost Balancing Account (PCBA)		1,933		17,837
Net WRAM and MCBA long-term payable		—		3,117
Other regulatory liabilities		1,616		1,316
Total Regulatory Liabilities		$	920,323	$	929,814

Short-term regulatory assets and liabilities are excluded from the above table. The short-term regulatory assets were $86.5 million as of September 30, 2026 and $72.5 million as of December 31, 2025. The short-term regulatory assets as of September 30, 2026 primarily consisted of IRMA, M-WRAM, GDBA, and ICBA receivables. As of December 31, 2025, the short-term regulatory assets primarily consisted of IRMA, M-WRAM, and ICBA receivables.

The short-term portion of regulatory liabilities was $89.9 million as of September 30, 2026 and $25.5 million as of December 31, 2025. The short-term regulatory liabilities as of September 30, 2026 consisted of PFAS settlement proceeds (see Note 9 of the Notes to Unaudited Condensed Consolidated Financial Statements), PCBA regulatory liabilities, CEBA regulatory liabilities, HCBA regulatory liabilities, and ICBA regulatory liabilities. As of December 31, 2025, the short-term regulatory liabilities primarily consisted of TCJA regulatory liabilities, ICBA regulatory liabilities, and PFAS settlement proceeds.